Polypid Stock Performance
| PYPD Stock | USD 3.07 0.09 3.02% |
On a scale of 0 to 100, PolyPid holds a performance score of 3. The company holds a Beta of 1.03, which implies a somewhat significant risk relative to the market. PolyPid returns are very sensitive to returns on the market. As the market goes up or down, PolyPid is expected to follow. Please check PolyPid's maximum drawdown, as well as the relationship between the expected short fall and rate of daily change , to make a quick decision on whether PolyPid's historical price patterns will revert.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in PolyPid are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, PolyPid exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 3.19 | Five Day Return 4.42 | Year To Date Return 0.66 | Ten Year Return (99.46) | All Time Return (99.46) |
Last Split Factor 1:30 | Last Split Date 2023-09-21 |
1 | PolyPid Announces Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX to 800 Patients with a Concurrent Private Placemen... | 12/24/2024 |
2 | PolyPid stock poised for 2026 launch despite adjusted target from H.C. Wainwright By Investing.com - Investing.com South Africa | 12/26/2024 |
3 | PolyPid files for secondary offering | 01/21/2025 |
4 | PolyPid to Report Fourth Quarter and Full-Year 2024 Financial Results and Operational Highlights on February 12, 2025 | 01/29/2025 |
5 | PolyPid to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference | 01/30/2025 |
6 | PolyPid targets SHIELD II trial completion with top-line results in Q2 2025 | 02/12/2025 |
7 | PolyPid Ltd Q4 2024 Earnings Call Highlights Strategic Advances Amid Rising RD Costs | 02/13/2025 |
8 | PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX ... | 03/11/2025 |
| Begin Period Cash Flow | 5.7 M |
PolyPid |
PolyPid Relative Risk vs. Return Landscape
If you would invest 287.00 in PolyPid on December 18, 2024 and sell it today you would earn a total of 20.00 from holding PolyPid or generate 6.97% return on investment over 90 days. PolyPid is currently generating 0.2836% in daily expected returns and assumes 5.896% risk (volatility on return distribution) over the 90 days horizon. In different words, 52% of stocks are less volatile than PolyPid, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
PolyPid Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PolyPid's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PolyPid, and traders can use it to determine the average amount a PolyPid's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0481
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PYPD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.9 actual daily | 52 52% of assets are less volatile |
Expected Return
| 0.28 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average PolyPid is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PolyPid by adding it to a well-diversified portfolio.
PolyPid Fundamentals Growth
PolyPid Stock prices reflect investors' perceptions of the future prospects and financial health of PolyPid, and PolyPid fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PolyPid Stock performance.
| Return On Equity | -10.39 | ||||
| Return On Asset | -0.86 | ||||
| Current Valuation | 24.29 M | ||||
| Shares Outstanding | 10.19 M | ||||
| Price To Book | 3.95 X | ||||
| EBITDA | (26.41 M) | ||||
| Net Income | (29.02 M) | ||||
| Cash And Equivalents | 23.78 M | ||||
| Cash Per Share | 1.22 X | ||||
| Total Debt | 9.62 M | ||||
| Debt To Equity | 0.47 % | ||||
| Current Ratio | 2.87 X | ||||
| Book Value Per Share | 0.75 X | ||||
| Cash Flow From Operations | (21.96 M) | ||||
| Earnings Per Share | (4.91) X | ||||
| Market Capitalization | 30.32 M | ||||
| Total Asset | 25.22 M | ||||
| Retained Earnings | (267.33 M) | ||||
| Working Capital | 3.89 M | ||||
About PolyPid Performance
By analyzing PolyPid's fundamental ratios, stakeholders can gain valuable insights into PolyPid's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if PolyPid has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if PolyPid has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 51.95 | 54.55 | |
| Return On Tangible Assets | (1.40) | (1.47) | |
| Return On Capital Employed | (2.55) | (2.67) | |
| Return On Assets | (1.40) | (1.47) | |
| Return On Equity | 13.09 | 13.75 |
Things to note about PolyPid performance evaluation
Checking the ongoing alerts about PolyPid for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PolyPid help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PolyPid had very high historical volatility over the last 90 days | |
| PolyPid has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (29.02 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| PolyPid currently holds about 23.78 M in cash with (21.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.22. | |
| Roughly 25.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX ... |
- Analyzing PolyPid's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PolyPid's stock is overvalued or undervalued compared to its peers.
- Examining PolyPid's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PolyPid's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PolyPid's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PolyPid's stock. These opinions can provide insight into PolyPid's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for PolyPid Stock analysis
When running PolyPid's price analysis, check to measure PolyPid's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PolyPid is operating at the current time. Most of PolyPid's value examination focuses on studying past and present price action to predict the probability of PolyPid's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PolyPid's price. Additionally, you may evaluate how the addition of PolyPid to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |